James F. Reddoch - 19 May 2022 Form 4 Insider Report for Royalty Pharma plc (RPRX)

Role: EVP & Chief Scientific Officer
Signature: /s/ Sean Weisberg, as Attorney-in-Fact for James F. Reddoch
Issuer symbol: RPRX
Transactions as of: 19 May 2022
Transactions value $: -$3,033,128
Form type: 4
Filing time: 23 May 2022, 16:57:36 UTC
Previous filing: 30 Dec 2021
Next filing: 31 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RPRX	Class A Ordinary Shares	Sale	-$3.03M	-75K	-6.41%	$40.44	1.1M	19 May 2022	By Reddoch RPI LLC	F1
holding	RPRX	Class A Ordinary Shares						25K	19 May 2022	By IRA

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.35 to $40.60 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.35 to $40.60 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.